As of 2024-12-12, the EV/EBITDA ratio of Abingdon Health PLC (ABDX.L) is -7.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ABDX.L's latest enterprise value is 13.08 mil GBP. ABDX.L's TTM EBITDA according to its financial statements is -1.79 mil GBP. Dividing these 2 quantities gives us the above ABDX.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 11.9x | 11.0x |
| Forward P/E multiples | 12.0x - 16.0x | 14.9x |
| Fair Price | (10.94) - (10.84) | (11.83) |
| Upside | -245.9% - -244.6% | -257.7% |
| Date | EV/EBITDA |
| 2024-12-10 | -7.57 |
| 2024-12-09 | -7.88 |
| 2024-12-06 | -7.88 |
| 2024-12-05 | -7.62 |
| 2024-12-04 | -7.88 |
| 2024-12-03 | -7.85 |
| 2024-12-02 | -7.15 |
| 2024-11-29 | -6.78 |
| 2024-11-28 | -7.05 |
| 2024-11-27 | -7.05 |
| 2024-11-26 | -7.05 |
| 2024-11-25 | -7.05 |
| 2024-11-22 | -7.05 |
| 2024-11-21 | -7.05 |
| 2024-11-20 | -7.05 |
| 2024-11-19 | -7.05 |
| 2024-11-18 | -7.57 |
| 2024-11-15 | -7.57 |
| 2024-11-14 | -7.31 |
| 2024-11-13 | -7.31 |
| 2024-11-12 | -7.57 |
| 2024-11-11 | -7.57 |
| 2024-11-08 | -7.57 |
| 2024-11-07 | -7.57 |
| 2024-11-06 | -7.62 |
| 2024-11-05 | -7.57 |
| 2024-11-04 | -7.83 |
| 2024-11-01 | -7.57 |
| 2024-10-31 | -7.57 |
| 2024-10-30 | -7.83 |
| 2024-10-29 | -7.57 |
| 2024-10-28 | -8.09 |
| 2024-10-25 | -8.09 |
| 2024-10-24 | -8.09 |
| 2024-10-23 | -8.36 |
| 2024-10-22 | -8.09 |
| 2024-10-21 | -8.48 |
| 2024-10-18 | -8.88 |
| 2024-10-17 | -8.88 |
| 2024-10-16 | -8.88 |
| 2024-10-15 | -9.40 |
| 2024-10-14 | -8.62 |
| 2024-10-11 | -8.62 |
| 2024-10-10 | -8.62 |
| 2024-10-09 | -8.62 |
| 2024-10-08 | -8.88 |
| 2024-10-07 | -9.14 |
| 2024-10-04 | -9.14 |
| 2024-10-03 | -9.14 |
| 2024-10-02 | -9.14 |